CODX Co-Diagnostics Corp: Forward Price-to-Revenue Multiple

The stability of Co-Diagnostics, Inc. (CODX) is underpinned by the humanitarian status of medicine and the absence of geopolitical sanctions. Capitalization is based on the sale of PCR systems and the licensing of molecular developments. Demand for diagnostics is independent of economic cycles, exhibiting a winter peak. The forward P/S ratio reflects market expectations, where the value of 4.00 characterizes this valuation level relative to expected sales.

codiagnostics.com - CODX Market Cap to Projected Revenue (period 07/04/2022 - 11/13/2026)

Metric breakdowns and analytics for CoDx (CODX)

- market price and analyst price targets:

Price Chart Co-Diagnostics|CODX - Average Forecast Price

- company stock capitalization data:

Market Valuation CoDx|CODX - Full Takeover Company Value

- business book valuation details:

Book Value per Share Co-Diagnostics|CODX - Accounting Capitalization|Market Capitalization to Book Value Ratio codiagnostics.com|CODX - Company Total Asset Base

- debt and liquidity details:

- financial results and valuation multiples details:

CODX - Net Financial Result|Future Profit Co-Diagnostics, Inc.|CODX - Market Price to Net Income Ratio|Forward P/E Multiple Co-Diagnostics Corp|CODX - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple CoDx|CODX - Operating profit before deduction of amortization|Earnings per share for the last twelve months Co-Diagnostics|CODX - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months codiagnostics.com|CODX - Earnings per share increase in current year|Earnings growth forecast for next year Co-Diagnostics, Inc.

- sales and revenue indicators:

CODX - Company Gross Revenue|Company Projected Revenue Co-Diagnostics|CODX - Market Cap to Revenue Ratio|Forward P/S Multiple CoDx

Basic company analysis:CODX (Co-Diagnostics)

DNA sequencing automation at Co-Diagnostics, Inc. (CODX) creates a foundation for revenue scaling, yet the forward P/S ratio allows for an assessment of how much the market is willing to pay a premium for this technological potential. Analyzing this metric compares market capitalization with expected sales volume to identify whether the asset is overheated or possesses hidden growth potential, which determines the fundamental stability of the investment amid inflationary pressures.

Competitor analysis for Co-Diagnostics, Inc.

Price-to-Projected Revenue Ratio Agilent A|Quest Diagnostics Inc. (DGX) - Market Cap to Future Revenue Ratio|ILMN: Forward Price-to-Revenue Multiple|Projected Price to Revenue Exact Sciences Inc. (EXAS)|RVTY: Forward P/S Multiple|Market Cap to Projected Revenue BIO|NNNN (Anbio) - Forward P/S Multiple|Sotera Health Corp (SHC) - Market Cap to Expected Sales Ratio|Forward P/S Multiple QDEL|Forward P/S Multiple OPKO Health Corp. (OPK)|Forward P/S Multiple CDNA (CareDx, Inc)|Projected Price to Revenue maravai.com|FLGT - Price-to-Projected Revenue Ratio|LAB (Standard BioTools Inc) - Market Cap to Projected Revenue|Cytek Bio (CTKB) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio OraSure Corp (OSUR)|Price-to-Projected Revenue Ratio Exagen Inc|mdxhealth.com (MDXH) - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple LUCD (Lucid Diagnostics)|Price to Expected Revenue Ratio PRE|Forward P/S Multiple IMDX (Insight Molecular Diagnostics Inc)|Market Cap to Expected Sales Ratio Trinity Biotech PLC (TRIB)|ProPhase Labs, Inc. - Forward P/S Multiple|ainos.com (AIMD) - Forward Price-to-Revenue Multiple|HeartSciences (HSCS) - Price-to-Projected Revenue Ratio|BMRA - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CDIO|ONCO: Forward Price to Sales|Forward P/S Multiple VRAX|Market Cap to Expected Sales Ratio bluejaydx.com|Price-to-Projected Revenue Ratio Aspira Women's Health Inc. AWH|AXDX: Market Cap to Projected Revenue|centogene.com - Forward P/S Multiple|Enzo Biochem, Inc. (ENZ) - Forward Price-to-Revenue Multiple|FRES (fresh2.co) - Forward Price-to-Revenue Multiple|GENE - Market Cap to Expected Sales Ratio|ME (23andMe) - Forward P/S Multiple|Forward Price-to-Revenue Multiple Psychemedics Corp. (PMD)